Why the Same Skincare Ingredient Heals One Person and Harms Another: A Dermatologist's Explanation
American skincare culture runs on recommendations. A friend raves about a vitamin C serum. A coworker swears her retinol prescription changed her life. Social media algorithms serve you testimonials from people whose skin looks exactly like what you want yours to become. So you purchase the product, follow the instructions carefully, and wait—only to be met with irritation, breakouts, or simply nothing at all.
This experience is extraordinarily common, and it reflects something fundamental about human biology: your skin is not a generic surface. It is a living organ shaped by genetics, microbial ecosystems, hormonal patterns, and metabolic processes that are uniquely yours. When dermatologists speak about personalized skincare, they are not invoking a marketing phrase. They are describing a clinical reality that has significant implications for how treatments are selected, adjusted, and monitored.
The Genetic Foundation of Skin Response
Pharmacogenomics—the study of how an individual's genetic makeup influences their response to drugs and bioactive compounds—has traditionally been applied in fields like oncology and cardiology. Its relevance to dermatology, however, is increasingly well-documented.
Consider retinoids, among the most thoroughly researched topical ingredients in existence. Retinoic acid exerts its effects by binding to nuclear receptors that regulate gene expression in skin cells. But the efficiency of that binding, and the downstream cellular response it triggers, is partly governed by genetic variants in the genes encoding those receptors. Some individuals carry variants that produce a more sensitive receptor response, meaning they experience significant results—and significant irritation—at low concentrations. Others have variants associated with reduced receptor sensitivity, which may explain why certain patients tolerate high-strength retinoids without difficulty while others struggle with even gentle formulations.
Similarly, variants in genes responsible for melanin synthesis and distribution affect how a person's skin responds to brightening agents such as kojic acid or tranexamic acid. What reliably fades post-inflammatory hyperpigmentation in one patient may produce minimal visible change in another, not because the product is ineffective in an absolute sense, but because the underlying pigmentation pathway it targets operates differently between individuals.
Your Skin Microbiome: An Invisible Variable
The skin microbiome—the community of bacteria, fungi, and other microorganisms residing on and within the skin—plays a decisive role in how topical ingredients behave after application. This ecosystem varies substantially from person to person, influenced by geography, diet, antibiotic history, hygiene practices, and even the water quality in a given region of the country.
Niacinamide offers a useful illustration. This B vitamin derivative is widely praised for its tolerability and its benefits in addressing enlarged pores, uneven tone, and barrier dysfunction. For most individuals, it performs exactly as described. Yet a subset of users report flushing, redness, or a sensation of warmth after application—a response that has been linked, in part, to the conversion of niacinamide to nicotinic acid by certain skin-resident bacteria. Individuals harboring higher concentrations of those bacterial species may experience this conversion more readily, producing a localized inflammatory response that their peers, with different microbiome compositions, never encounter.
Acne treatments present another dimension of this complexity. Benzoyl peroxide and certain antibiotic formulations work by targeting Cutibacterium acnes, the bacterium implicated in inflammatory acne. However, the specific strains of this organism colonizing your skin—and the degree to which those strains have developed resistance—vary considerably. Two patients presenting with clinically similar acne may respond very differently to identical treatment protocols because their microbial populations are distinct.
Metabolic Processing and Ingredient Activation
Some skincare ingredients are not biologically active in the form in which they are applied. They require enzymatic conversion within the skin to reach their functional state. This is particularly relevant with certain vitamin C derivatives and retinol-based products.
Retinol, for instance, must be converted to retinaldehyde and then to retinoic acid—the compound that actually interacts with skin receptors—through a sequence of enzymatic steps. The efficiency of these enzymes varies between individuals. A person with highly active conversion enzymes may derive results from a modest over-the-counter retinol that are comparable to what another person achieves only with a prescription-strength tretinoin. Conversely, someone with reduced enzymatic activity may find that even high-concentration retinol products yield limited visible improvement, leading them to conclude—incorrectly—that retinoids simply do not work for their skin.
This metabolic variability also affects ingredient interactions. When multiple actives are layered together, the enzymatic environment of the skin determines how each compound is processed, and at what rate. This is one reason that a combination approach that proves transformative for one patient can overwhelm another's skin chemistry entirely.
Barrier Integrity as a Modulating Factor
The condition of the skin barrier—its lipid composition, transepidermal water loss rate, and structural integrity—functions as a critical variable in ingredient penetration and tolerability. Individuals with compromised barrier function, whether due to genetic predisposition (as seen in those with filaggrin gene mutations associated with atopic dermatitis) or acquired damage from environmental exposure or over-exfoliation, absorb topical ingredients at rates that differ significantly from those with intact barriers.
This means that an ingredient concentration labeled as suitable for sensitive skin may still penetrate too aggressively in a person whose barrier is already disrupted, producing inflammation that would not occur in someone with healthier baseline barrier function. Dermatologists assess barrier status—sometimes through formal testing, sometimes through careful clinical history—before recommending active ingredient concentrations, precisely because penetration rates shift the entire risk-benefit calculation.
What Dermatologists Actually Evaluate Before Making Recommendations
When a board-certified dermatologist recommends a treatment protocol, the decision involves considerably more than matching an ingredient to a skin concern. A thorough clinician will consider the patient's fitzpatrick skin type and its implications for pigmentation response, a detailed history of prior reactions and tolerability patterns, current barrier integrity and hydration status, any known systemic conditions or medications that may alter skin behavior, and the patient's geographic environment—humidity levels, UV exposure, and even local water mineral content can influence how products perform over time.
This is why dermatologist-recommended routines are not simply curated product lists. They are individualized clinical decisions that account for the full picture of a patient's skin biology.
The Practical Takeaway for Your Skincare Decisions
Understanding that ingredient response is biologically individual should reframe how you interpret both enthusiastic recommendations and your own product experiences. A best-seller designation reflects aggregate consumer experience, not a guarantee of personal efficacy or safety. The person whose testimonial convinced you to purchase a product has a different genetic profile, a different microbiome, and a different metabolic environment than you do.
If you have experienced unexplained reactions to well-regarded products, or if treatments that work for nearly everyone in your social circle produce no results for you, a consultation with a dermatologist is warranted—not as a last resort, but as the most efficient path to understanding what your specific skin actually needs. Personalized care is not a luxury add-on to skincare. It is the clinical standard from which effective treatment begins.
